Last Updated on October 6, 2024 by The Health Master
Ahmedabad: A study carried out by a team from Gujarat Technological University (GTU) claimed that some of the drugs used in the treatment of diabetes and hypertension were found to have nitrosamine content in amounts higher than the limits prescribed.
Nitrosamines are considered to be carcinogens or cancer-causing impurities. GTU officials said that about 60 drugs of 15 brands were chosen for the study.
“The purpose of the study was to find nitrosamine content as some lots of the drugs exported to the US were returned over high content. It motivated us to take up the research,” said an official.
The international standards prescribe 0.03 micrograms per gram limit for nitrosamines.
The researchers claimed that in some of the drugs, the nitrosamine quantity was up to 30 times higher than what was prescribed.
IPC invites laboratories to join Testing Programme for quality assurance
All Blood Centres / Banks to have NAT-PCR test by 2025
USFDA issues EIR to Indoco Remedies, Goa
Moving towards zero counterfeiting to ease traceability and authentication
Govt approves 5 Medical Devices Companies under PLI scheme
USFDA issues Form 483 with 3 observation to Zydus, Ahmedabad
Drug recall: Thyronorm tablets recalled due to this reason
Drug alert: 48 out of 1497 samples declared as NSQ in March 2023
Wet Granulation vs Dry Granulation: Understanding the Key Differences
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
